← Open Payments lookup

CHELSEA SHAFRANEK: Open Payments

NPI 1710546411 · ALLSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$400 in 18 payments from 12 companies in 2025. Trend: 2023 $1,022 · 2024 $1,301 · 2025 $400

Food & beverage: $400
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$62
Novo Nordisk Inc2$50
Lundbeck LLC2$48
Otsuka America Pharmaceutical, Inc.2$43
PFIZER INC.2$35
Boehringer Ingelheim Pharmaceuticals, Inc.1$29
Lilly USA, LLC1$26
Merck Sharp & Dohme LLC1$25
ABBVIE INC.1$24
Ardelyx, Inc.1$22

Products named: REXULTI, ELIQUIS, JARDIANCE, MOUNJARO, GARDASIL 9, UBRELVY, IBSRELA, Kerendia.

Industry payments across MA — which companies pay providers there.